Evaluation of a clinical pharmacogenetics model to predict methotrexate response in patients with rheumatoid arthritis.
López-Rodríguez R, Ferreiro-Iglesias A, Lima A, Bernardes M, Pawlik A, Paradowska-Gorycka A, Świerkot J, Slezak R, Gonzalez-Alvaro I, Narvaez J, Pérez-Pampín E, Mera-Varela A, Vidal-Bralo L, Acuña-Ochoa JG, Conde C, Gonzalez A.
López-Rodríguez R, et al. Among authors: conde c.
Pharmacogenomics J. 2018 Jul;18(4):539-545. doi: 10.1038/s41397-018-0017-5. Epub 2018 Mar 8.
Pharmacogenomics J. 2018.
PMID: 29520081